Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
Cue Health Provides Molecular COVID-19 Testing To MLB Clubs During The Postseason And World Series
Cue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, and Major League Baseball (MLB) today announced that Cue has been providing all Clubs, as well as the league office, with
Cowen & Co. Initiates Coverage On Cue Health with Outperform Rating, Announces Price Target of $14
Cowen & Co. analyst Charles Rhyee initiates coverage on Cue Health (NASDAQ:HLTH) with a Outperform rating and announces Price Target of $14.
Cue Health, Google Cloud Join Forces To Track Respiratory Viral Variants
Cue Health Inc (NASDAQ:HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to…
Cue Health Reports Collab With Google Health ‘To Add Variant Sequencing, Tracking, And Predictive Capabilities To Its Cue Platform’
Cue Health Inc. (NASDAQ:HLTH), a mission-driven healthcare technology company, today introduced its new collaboration with Google Cloud to address the nation's critical need for real-time respiratory viral
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 5)
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 4)
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA Calendar
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 30)
51 Biggest Movers From Yesterday
Gainers
Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported
Q2 earnings of $0.00 per share on sales of $3.40 million.